This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Feb. 22, 2011 /PRNewswire/ -- Synergetics USA, Inc. (Nasdaq: SURG) announced today that it will host a conference call the morning of
Thursday, March 10, 2011, at
10:30 a.m. Eastern time to review the Company's results for the fiscal second quarter ended
January 31, 2011. A news release announcing the second quarter's results will be issued on
Wednesday, March 9, 2011, after market close.
During the call,
David Hable, Synergetics' President and Chief Executive Officer, and
Pamela G. Boone, Executive Vice President and Chief Financial Officer, will provide an overview of the second quarter performance and business highlights.
The toll free dial-in number to participate live on this call is (800) 447-0521, confirmation code 29114962. For callers outside the U.S., the number is (847) 413-3238. The conference call will also be simulcast live at
http://www.synergeticsusa.com. An online replay will be available on the Company's website for approximately 30 days.
About Synergetics USA, Inc.
Through continuous improvement and development of our people, our
mission is to design, manufacture and market innovative microsurgical instruments and consumables of the highest quality in order to assist and enable surgeons who perform microsurgery around the world to provide a better quality of life for their patients.
Synergetics USA, Inc. ("Synergetics USA" or the "Company") is a leading supplier of precision microsurgery instrumentation. The Company's primary focus is on the microsurgical disciplines of ophthalmology and neurosurgery. Our distribution channels include a combination of direct and independent sales organizations and important strategic alliances with market leaders. The Company's product lines focus upon precision engineered, microsurgical, hand-held instruments and the delivery of various energy modalities for the performance of less invasive microsurgery including: (i) laser energy, (ii) ultrasonic energy, (iii) radio frequency for electrosurgery and oblation and (iv) visible light energy for illumination, and where applicable, simultaneous infusion (irrigation) of fluids into the operative field. The Company's website address is
Forward-Looking StatementsSome statements in this release may be "forward-looking statements" for the purposes of the Private Securities Litigation Reform Act of 1995. In some cases forward-looking statements can be identified bywords such as "believe," "expect," "anticipate," "plan," "potential,""continue" or similar expressions. Such forward-looking statementsinclude risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks and uncertainties are discussed in Synergetics' Annual Report on Form 10-K for the year ended July 31, 2009, as updated from time to time in our filings with the Securities and Exchange Commission.
SOURCE Synergetics USA, Inc.